阿托伐他汀治疗对CHF患者血清脂联素及有关心衰标志物的影响被引量：3

导出

摘要目的观察阿托伐他汀对慢性心力衰竭(chronic heart failur,CHF)患者血清脂联素(adiponectin,APN)和有关心衰标志物的影响。方法测定症状基本得到控制的CHF患者在常规抗心衰基础上经阿托伐他汀治疗4周前后APN与NT-proBNP、TNF-α、IL-6水平。结果在常规抗心衰药物治疗基础上加用阿托伐他汀治疗4周,TNF-α、IL-6水平较对照组降低(P<0.05),APN和NT-proBNP水平差异无统计学意义(P>0.05)。结论短期应用阿托伐他汀治疗CHF患者,APN和NT-proBNP水平无变化。

作者张凯

机构地区湖南省长沙市第一医院

出处《实用预防医学》 CAS 2010年第2期345-346,共2页 Practical Preventive Medicine

关键词阿托伐他汀慢性心力衰竭血清脂联素心衰标志物

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献12

1Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function[J]. J Clin Endocrinol Metab, 2004, 89: 2563 - 2568.
2Kobayashi K. Adipokines: therapeutic targets for metabolic syndrome [J]. Curr Drug Targets, 2005, 6:525-529.
3Pliquett RU, Cornish KG, Peuler JD, et al. Simvastatin normalizes autonomic neural control in experimental heart failure [J ]. Circulation, 2003,107:2493- 2498.
4李洪林,杨思进.他汀类药物调脂作用外的临床研究进展[J].中国药房,2007,18(17):1352-1354. 被引量：8
5Banersachs J, Galuppo P, FraccaroIlo D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction[J].Circulation, 2001, 104 (9) : 982.
6Yarnada T, Node K, Mine T, et al. Atorvastatin therapy associated with improvement in left ventrieular remodeling in a case of idiopathic dilated cardiomyopathy[J]. Am J Med Sci, 2006,332(6) :361 - 3.
7Strey CH, Young JM, Lainchbury JH, etal. Short - term statin treatment improves endothelial function and neumhormonal imbalance in norrnocholesterolaemic patients with non- ischaemic heart failure[J ]. Heart, 2006,92 ( 11 ) : 1537 - 8.
8Yamada T, Node K, Mine T. Long - term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study[J]. Am Heart J, 2007,153(6) : 1055. e1 - 8.
9Cleland JG, Abdellah AT, Khaleva O, et al. Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure[J]. Eur J Heart Fail, 2007,9 (10) : 1070 - 3.
10张凯,谭茗月,李安莹.慢性心力衰竭患者血清脂联素的浓度及临床意义[J].实用预防医学,2007,14(5):1403-1405. 被引量：4

二级参考文献32

1倪占玲,赵水平.他汀类与败血症[J].中国药理学通报,2005,21(10):1161-1163. 被引量：2
2Merx MW,Liehn EA,Graf J,et al.Statin treatment after onset of sepsis in a murine model improves survival[J].Circulation,2005,112(2):117.
3Thomsen RW,Hundborg HH,Johnsen SP,et al.Staitn use and mortality within 180 days after bactermia:a population-based cohort stuty[J].Crit Care Med,2006,34(4):1 270.
4Schmidt H,Hennen R,Keller A,et al.Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome[J].Intensive Care Med,2006,32(8):1 248.
5Simons M,Schwarzler F,Lutjohann D,et al.Treatment with simvastatin in normcholesterolemic patients with Alzheimer's disease:A 26-week randomized,placebo-controlled,double-blind trial[J].Ann Neurol,2002,52(3):346.
6Petanceska SS,DeRosa S,Olm V,et al.Statin therapy for Alzheimer's disease:Will it work[J].J Mol Neurosci,2002,19(1):155.
7SparksDL,Sabbagh M,Connor D,et al.Statin therapy in Alzheimer's disease[J].Acta Neurol Scand Suppl,2006,185(1):78.
8Wehr H,Bednarska-Makaruk M.Will statins be used in dementia treatment[J].Neurol Neurochir Pol,2005,39(4):318.
9Pliquett RU,Cornish KG,Peuler JD,et al.Simvastatin normalizes autonomic neural control in experimental heart failure[J].Circulation,2003,107(19):2 493.
10Bauersachs J,Galuppo P,Fraccarollo D,et al.Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction[J].Circulation,2001,104(9):982.